These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 16627879

  • 1. Systemic effects of orally-administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice.
    Morioka I, Wong RJ, Abate A, Vreman HJ, Contag CH, Stevenson DK.
    Pediatr Res; 2006 May; 59(5):667-72. PubMed ID: 16627879
    [Abstract] [Full Text] [Related]

  • 2. The effectiveness of oral tin mesoporphyrin prophylaxis in reducing bilirubin production after an oral heme load in a transgenic mouse model.
    DeSandre GH, Wong RJ, Morioka I, Contag CH, Stevenson DK.
    Biol Neonate; 2006 May; 89(3):139-46. PubMed ID: 16205054
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model.
    Fujioka K, Kalish F, Wong RJ, Stevenson DK.
    Pediatr Res; 2016 Feb; 79(2):251-7. PubMed ID: 26488552
    [Abstract] [Full Text] [Related]

  • 4. Effects of zinc deuteroporphyrin bis glycol on newborn mice after heme loading.
    He CX, Campbell CM, Zhao H, Kalish FS, Schulz S, Vreman HJ, Wong RJ, Stevenson DK.
    Pediatr Res; 2011 Nov; 70(5):467-72. PubMed ID: 21785387
    [Abstract] [Full Text] [Related]

  • 5. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins.
    Wong RJ, Vreman HJ, Schulz S, Kalish FS, Pierce NW, Stevenson DK.
    J Perinatol; 2011 Apr; 31 Suppl 1():S35-41. PubMed ID: 21448202
    [Abstract] [Full Text] [Related]

  • 6. Effects of metalloporphyrins on heme oxygenase-1 transcription: correlative cell culture assays guide in vivo imaging.
    Hajdena-Dawson M, Zhang W, Contag PR, Wong RJ, Vreman HJ, Stevenson DK, Contag CH.
    Mol Imaging; 2003 Jul; 2(3):138-49. PubMed ID: 14649057
    [Abstract] [Full Text] [Related]

  • 7. Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1.
    Zhang W, Contag PR, Hardy J, Zhao H, Vreman HJ, Hajdena-Dawson M, Wong RJ, Stevenson DK, Contag CH.
    J Mol Med (Berl); 2002 Oct; 80(10):655-64. PubMed ID: 12395150
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Duration of action and tissue distribution of zinc protoporphyrin in neonatal rats.
    Rodgers PA, Seidman DS, Wei PL, Dennery PA, Stevenson DK.
    Pediatr Res; 1996 Jun; 39(6):1041-9. PubMed ID: 8725267
    [Abstract] [Full Text] [Related]

  • 10. Oral administration of zinc deuteroporphyrin IX 2,4 bis glycol inhibits heme oxygenase in neonatal rats.
    Vallier HA, Rodgers PA, Stevenson DK.
    Dev Pharmacol Ther; 1991 Jun; 17(3-4):220-2. PubMed ID: 1841841
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG.
    Vreman HJ, Lee OK, Stevenson DK.
    Am J Med Sci; 1991 Dec; 302(6):335-41. PubMed ID: 1772116
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of heme oxygenase activity in newborn mice by azalanstat.
    Morisawa T, Wong RJ, Bhutani VK, Vreman HJ, Stevenson DK.
    Can J Physiol Pharmacol; 2008 Oct; 86(10):651-9. PubMed ID: 18841169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension.
    Botros FT, Schwartzman ML, Stier CT, Goodman AI, Abraham NG.
    Kidney Int; 2005 Dec; 68(6):2745-55. PubMed ID: 16316349
    [Abstract] [Full Text] [Related]

  • 17. In vitro inhibition of adult rat intestinal heme oxygenase by metalloporphyrins.
    Vreman HJ, Gillman MJ, Stevenson DK.
    Pediatr Res; 1989 Oct; 26(4):362-5. PubMed ID: 2797950
    [Abstract] [Full Text] [Related]

  • 18. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations.
    Appleton SD, Chretien ML, McLaughlin BE, Vreman HJ, Stevenson DK, Brien JF, Nakatsu K, Maurice DH, Marks GS.
    Drug Metab Dispos; 1999 Oct; 27(10):1214-9. PubMed ID: 10497150
    [Abstract] [Full Text] [Related]

  • 19. Characterization of porphyrin heme oxygenase inhibitors.
    Vreman HJ, Cipkala DA, Stevenson DK.
    Can J Physiol Pharmacol; 1996 Mar; 74(3):278-85. PubMed ID: 8773407
    [Abstract] [Full Text] [Related]

  • 20. Metalloporphyrins, used for HO-1 inhibition, themselves affect hepatic microcirculation, liver function, and hepatocellular integrity.
    Scheingraber S, Messner S, Matt S, Abel K, Goger S, Kötner K, Schilling MK, Menger MD.
    Microcirculation; 2009 May; 16(4):355-63. PubMed ID: 19301178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.